TickerFacts.

20/20 Biolabs, Inc. (AIDX): Gross Profit

Annual figures by period end, from SEC filings.

$604.5K
Year ended 2025-12-31
$643.1K
Trailing 12 months to 2026-06-30
2024-12-31: $360.3K2025-12-31: $604.5K$604.5K
2024-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$604.5K+67.8%2026-03-31, From 2025-01-01
2024-12-31$360.3Kn/a2026-03-31, From 2024-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
20/20 Biolabs, Inc. (AIDX)2025-12-31$604.5K+67.8%
iSpecimen Inc. (ISPC)2025-12-31$24.1K-99.4%
OneMedNet Corp (ONMD)2025-12-31-$503.0Kn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31$262.9K+29.4%
MaxCyte, Inc. (MXCT)2025-12-31$26.80M-15.0%
NeoGenomics Inc (NEO)2025-12-31$314.29M+8.3%
UL Solutions Inc. (ULS)2025-12-31$1.51B+8.5%
Incyte Corp (INCY)2025-12-31$4.77B+21.4%
Icon PLC (ICLR)2024-12-31$2.34B+0.4%

Compare AIDX, ISPC, ONMD, CBIH side by side · Screen every company in Services-Testing Laboratories ↗